Mahshid Mohammadipour
Research Subjects
Research Interests
Mahshid Mohammadipour has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ali Jahanian-Najafabadi
Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
3 shared publications - Mehryar Habibi Roudkenar
Burn and Regenerative Medicine Research Center, School of Medicine, Velayat Hospital, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications - Raheleh Halabian
Applied Microbiology Research Center, Biomedicine Technologies Institute Baqiyatallah University of Medical Sciences, Tehran, Iran
3 shared publications - Amaneh Mohammadi Roushandeh
Department of Anatomy, School of Biomedical Sciences, Medicine & Health, UNSW Sydney, Sydney, NSW, 2052, Australia
2 shared publications Ahmad Kazemi
1 shared publication- Ali Arabkhazaeli
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by InkVista Publishing House in Journal of Iranian Blood Transfusion
- Vol. 23 (2) , 125-134
Optimization of Platelet-Derived Exosome Isolation Using Multiple Centrifugation Steps Based on Polymer-precipitation
A B S T R A C T Background and Objectives Exosomes are a subclass of extracellular vesicles (EVs) released via the endosomal pathway, ranging in diameter from 30 to 150 nm. They carry a diverse of biological macromolecules such as DNA, RNA, and proteins. Platelet-derived exosomes are the most abundant nanoparticles in the bloodstream. Given the need for simple ...
- 1 July 2026
- Published by InkVista Publishing House in Journal of Iranian Blood Transfusion
- Vol. 23 (2) , 125-134
Open AccessOptimization of Platelet-Derived Exosome Isolation Using Multiple Centrifugation Steps Based on Polymer-precipitation
A B S T R A C T Background and Objectives Exosomes are a subclass of extracellular vesicles (EVs) released via the endosomal pathway, ranging in diameter from 30 to 150 nm. They carry a diverse of biological macromolecules such as DNA, RNA, and proteins. Platelet-derived exosomes are the most abundant nanoparticles in the bloodstream. Given the need for simple ...
- 1 December 2025
- Published by InkVista Publishing House in Journal of Iranian Blood Transfusion
- Vol. 22 (4) , 265-276
A Comparative Study of Quality Metrics in Leukoreduced Red Blood Cell Units Following Filtration with Two Distinct Inline Filter Blood Bags
- 1 December 2025
- Published by InkVista Publishing House in Journal of Iranian Blood Transfusion
- Vol. 22 (4) , 265-276
A Comparative Study of Quality Metrics in Leukoreduced Red Blood Cell Units Following Filtration with Two Distinct Inline Filter Blood Bags
- Open Access
- 1 July 2023
- Published by Apex Publishing in Journal of Research in Applied and Basic Medical Sciences
- Vol. 9 (3) , 123-129
An affinity-based method for the purification of platelet factor 4 from outdated platelet concentrates
Background & Aims: Platelet factor 4 (PF4) is considered as a chemokine mainly strode in the granules of platelets. Its important role in heparin-induced thrombocytopenia (HIT) was the basis of many investigations about this chemokine. High affinity to heparin was used to extract of PF4 from platelet concentrates (PCs). Despite many advantages ...
- 1 July 2023
- Published by Apex Publishing in Journal of Research in Applied and Basic Medical Sciences
- Vol. 9 (3) , 123-129
Open AccessAn affinity-based method for the purification of platelet factor 4 from outdated platelet concentrates
Background & Aims: Platelet factor 4 (PF4) is considered as a chemokine mainly strode in the granules of platelets. Its important role in heparin-induced thrombocytopenia (HIT) was the basis of many investigations about this chemokine. High affinity to heparin was used to extract of PF4 from platelet concentrates (PCs). Despite many advantages ...
- Open Access
- 1 January 2016
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 5 (1) , 41-49
In silicoanalysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate
Fahimi H, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):41-49. http://dx.doi.org/10.7774/cevr.2016.5.1.41
- 1 January 2016
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 5 (1) , 41-49
Open AccessIn silicoanalysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate
Fahimi H, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):41-49. http://dx.doi.org/10.7774/cevr.2016.5.1.41
- 1 April 2013
- Published by Elsevier in Archives of Medical Research
- Vol. 44 (3) , 185-193
HIF-1α Confers Resistance to Induced Stress in Bone Marrow-derived Mesenchymal Stem Cells
- 1 April 2013
- Published by Elsevier in Archives of Medical Research
- Vol. 44 (3) , 185-193
HIF-1α Confers Resistance to Induced Stress in Bone Marrow-derived Mesenchymal Stem Cells
- Open Access
- 1 March 2012
- Published by Elsevier in Cell Stress and Chaperones
- Vol. 17 (2) , 181-190
Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses
- 1 March 2012
- Published by Elsevier in Cell Stress and Chaperones
- Vol. 17 (2) , 181-190
Open AccessAdenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses
- 7 March 2010
- Published by Springer Nature in Biotechnology Letters
- Vol. 32 (6) , 803-809
High-level expression of functional recombinant human coagulation factor VII in insect cells
Recombinant coagulation factor VII (FVII) is used as a potential therapeutic intervention in hemophilia patients who produce antibodies against the coagulation factors. Mammalian cell lines provide low levels of expression, however, the Spodoptera frugiperda Sf9 cell line and baculovirus expression system are powerful systems for high-level expression of recombinant proteins, but due to the lack of endogenous vitamin K-dependent carboxylase, expression of functional FVII using this system is impossible. In the present study, we report a simple but versatile method to overcome the defect for high-level expression of the functional recombinant coagulation FVII in Sf9 cells. This method involves simultaneous expression of both human γ-carboxylase (hGC) and human FVII genes in the host. It may be possible to express other vitamin K-dependent coagulation factors using this method in the future.
- 7 March 2010
- Published by Springer Nature in Biotechnology Letters
- Vol. 32 (6) , 803-809
High-level expression of functional recombinant human coagulation factor VII in insect cells
Recombinant coagulation factor VII (FVII) is used as a potential therapeutic intervention in hemophilia patients who produce antibodies against the coagulation factors. Mammalian cell lines provide low levels of expression, however, the Spodoptera frugiperda Sf9 cell line and baculovirus expression system are powerful systems for high-level expression of recombinant proteins, but due to the lack of endogenous vitamin K-dependent carboxylase, expression of functional FVII using this system is impossible. In the present study, we report a simple but versatile method to overcome the defect for high-level expression of the functional recombinant coagulation FVII in Sf9 cells. This method involves simultaneous expression of both human γ-carboxylase (hGC) and human FVII genes in the host. It may be possible to express other vitamin K-dependent coagulation factors using this method in the future.